Phase I dose escalation study of concurrent palliative radiation therapy with sorafenib in three anatomical cohorts (Thorax, Abdomen, Pelvis): The TAP study

Murray, L orcid.org/0000-0003-0658-6455, Longo, J, Wan, J et al. (6 more authors) (2017) Phase I dose escalation study of concurrent palliative radiation therapy with sorafenib in three anatomical cohorts (Thorax, Abdomen, Pelvis): The TAP study. Radiotherapy and Oncology, 124 (1). pp. 74-79. ISSN 0167-8140

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 Elsevier B.V. This is an author produced version of a paper published in Radiotherapy and Oncology. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Palliative radiotherapy; Sorafenib; Drug–radiotherapy interactions; Phase I trial
Dates:
  • Published: July 2017
  • Accepted: 5 June 2017
  • Published (online): 28 June 2017
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 17 Jul 2017 12:52
Last Modified: 28 Jun 2018 00:38
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.radonc.2017.06.007

Share / Export

Statistics